Ferroptosis-related ACSL3 and ACTC1 predict metastasis-free survival for prostate cancer patients undergoing radical radiotherapy

Ferroptosis-related ACSL3 and ACTC1 predict metastasis-free survival for prostate cancer patients undergoing radical radiotherapy

Bibliographic Details
Main Authors:	Xu Shi, Dechao Feng, Ping Han, Wuran Wei
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Asian Journal of Surgery
Subjects:	Ferroptosis Prostate cancer Tumor immune microenvironment Biochemical recurrence Metastasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958422017869

Similar Items

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
by: Zhi-Bin Ke, et al.
Published: (2022-01-01)

Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients
by: Dechao Feng, et al.
Published: (2024-01-01)

Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer
by: Zhengtong Lv, et al.
Published: (2021-10-01)

Ureteric obstruction secondary to unusual metastasis of prostate cancer
by: Alexandar Blazevski, et al.
Published: (2020-07-01)

Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy
by: Dechao Feng, et al.
Published: (2022-02-01)

Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy
by: Dechao Feng, et al.
Published: (2023-08-01)

Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy
by: Dechao Feng, et al.
Published: (2022-04-01)

An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer
by: Wei-Zhen Zhu, et al.
Published: (2023-01-01)

Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients
by: Dechao Feng, et al.
Published: (2023-05-01)

ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
by: Yufei Yang, et al.
Published: (2022-11-01)

Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients
by: Dechao Feng, et al.
Published: (2022-09-01)

Metformin delays progression of prostate cancer: a retrospective study on 192 cases
by: TAN Xintao, et al.
Published: (2021-07-01)

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
by: Takuya Aizawa, et al.
Published: (2023-10-01)

Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels
by: Dennie Meijer, et al.
Published: (2019-07-01)

Partial salvage cryoablation of the prostate for local recurrent prostate cancer after primary radiotherapy: Step-by-step technique and outcomes
by: R. Boissier, et al.
Published: (2020-09-01)

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
by: Nina-Sophie Schmidt-Hegemann, et al.
Published: (2018-03-01)

Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
by: Xing Zhou, et al.
Published: (2022-01-01)

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
by: Sung-Woo Park, et al.
Published: (2020-12-01)

Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
by: Yuqian Gao, et al.
Published: (2020-05-01)

Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy
by: Paola Mapelli, et al.
Published: (2023-09-01)

A Five Glutamine-Associated Signature Predicts Prognosis of Prostate Cancer and Links Glutamine Metabolism with Tumor Microenvironment
by: Hai Wang, et al.
Published: (2023-03-01)

Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
by: Kun Jin, et al.
Published: (2020-01-01)

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
by: Vincent Q. Trinh, et al.
Published: (2019-04-01)

Outcomes of Salvage Prostate Cryotherapy: Real-life Experience of a Portuguese Oncologic Hospital
by: Luísa Jerónimo Alves, et al.
Published: (2021-09-01)

Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer
by: Shuichi Nishimura, et al.
Published: (2018-05-01)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
by: Zhenyu Jia, et al.
Published: (2019-06-01)

High-risk prostate cancer: factors predicting biochemical recurrence after radical prostatectomy
by: Albertas Ulys, et al.
Published: (2015-12-01)

A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa
by: Nina-Sophie Schmidt-Hegemann, et al.
Published: (2021-10-01)

Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
by: Alison K. Buxton, et al.
Published: (2022-12-01)

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer
by: Dechao Feng, et al.
Published: (2022-01-01)

Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy
by: Dae Hyuk Chung, et al.
Published: (2023-09-01)

Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer
by: Congzhe Ren, et al.
Published: (2023-03-01)

Analysis of factors affecting first serum prostate specific antigen level after radical prostatectomy for prostate cancer
by: ZHANG Jingqi, et al.
Published: (2019-08-01)

Perineural invasion as an independent predictor of biochemical recurrence in prostate cancer following radical prostatectomy or radiotherapy: a systematic review and meta-analysis
by: Li-jin Zhang, et al.
Published: (2018-02-01)

Efficacy and Safety of Brazilian Green Propolis in Biochemically Recurrent Prostate Cancer after Radical Prostatectomy: A Single-Arm Phase II Study
by: Takayuki Goto, et al.
Published: (2022-12-01)

Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
by: Xuan Liu, et al.
Published: (2022-06-01)

Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data
by: Salem Baldi, et al.
Published: (2022-12-01)

Clinicopathological Significances of Positive Surgical Resection Margin after Radical Prostatectomy for Prostatic Cancers: A Meta-Analysis
by: Minseok Kim, et al.
Published: (2022-09-01)

Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy
by: Zhang ZN, et al.
Published: (2018-10-01)

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
by: Yingxin Cai, et al.
Published: (2022-10-01)